C.M. Eandi

Discipline

Psychologie (4)

Type de document

Articles (11)

Co-auteur

Date

Source

Mot-clé

Patients (8) Patients (8) Eye (7) Treatment (6) Retinal (Visual pigment) (5) perte (4) maladie (4) Visual acuity (4) Retinal degeneration (4) Injections (4) Inflammation (4) maladie (4) temps (durée) (3) thérapie (3) Control (3) Vision (3) Time (3) Therapeutics (3) Retina (3) Human beings (3) Impact (3) Example (3) Epithelium (3) Edema (3) Optical coherence tomography (3) puits (2) modèle (2) membrane (2) analyse (2) dommage (2)

Documents écrit par C.M. Eandi (11) | parle de C.M. Eandi (0)

TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration.
A. Montesel et al. (1 avr. 2022)
Bilateral acute macular neuroretinopathy following COVID-19 infection.
C. Giacuzzo et al.
EIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY.
C.M. Eandi et al. (1 sept. 2021)
Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration.
M. Rispoli et al. (10 juin 2021)
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage.
F. Conti et al. (2021)
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration.
F. Lazzara et al. (2021)
Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice.
A. Montesel et al. (2021)
MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema.
G.E. Grieco et al. (3 oct. 2020)
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
C.M. Eandi et al.
Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient.
A. Montesel et al. (2020)
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery.
A. Spadaro et al. (2020)